NCT00928538

Brief Summary

The purpose of this study is to determine whether nurses can help at-risk women reduce the incidence of unintended pregnancy by providing them access to hormonal contraceptives in their homes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
344

participants targeted

Target at P50-P75 for phase_4 pregnancy

Timeline
Completed

Started Sep 2009

Longer than P75 for phase_4 pregnancy

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 26, 2009

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2009

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

March 30, 2016

Status Verified

March 1, 2016

Enrollment Period

3.7 years

First QC Date

June 25, 2009

Last Update Submit

March 28, 2016

Conditions

Keywords

Female ContraceptionHome VisitsCONTRACEPTIVE AGENTSCONTRACEPTIVE DEVICES

Outcome Measures

Primary Outcomes (1)

  • One month gaps in effective contraceptive use (defined as methods with which < 10% of women experience an accidental pregnancy during a year of typical use)

    Every three months after delivery for two years

Secondary Outcomes (1)

  • Unintended pregnancy

    Every three months after delivery for two years

Study Arms (2)

Usual NFP Care

NO INTERVENTION

Usual NFP care includes pregnancy planning and contraceptive advice during nurse home visits, with the prescription and dispensing of contraceptives provided through the women's primary care settings.

Enhanced NFP Care

EXPERIMENTAL

Enhanced NFP intervention includes usual NFP care plus the intervention that includes contraceptive administration and distribution in the home

Other: Enhanced NFP Care

Interventions

Usual NFP care plus the enhanced care that includes contraceptive administration and distribution during nurse home visits. Participants will have a choice of combined hormonal contraception (oral, patches or vaginal rings)or progestin-only contraception (oral or depomedroxyprogesterone acetate injections.

Enhanced NFP Care

Eligibility Criteria

Age15 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • English or Spanish speaking (or both)
  • Enrolled in the NFP (Nurse Family Partnership) program
  • weeks or less gestation.

You may not qualify if:

  • Not enrolled in the NFP program
  • More than 32 weeks gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Thurston County Public Health

Olympia, Washington, 98506, United States

Location

Seattle - King County Public Health

Seattle, Washington, United States

Location

Clark County Public Health

Vancouver, Washington, 98666, United States

Location

Related Publications (2)

  • Melnick AL, Rdesinski RE, Creach ED, Choi D, Harvey SM. The influence of nurse home visits, including provision of 3 months of contraceptives and contraceptive counseling, on perceived barriers to contraceptive use and contraceptive use self-efficacy. Womens Health Issues. 2008 Nov-Dec;18(6):471-81. doi: 10.1016/j.whi.2008.07.011. Epub 2008 Oct 15.

    PMID: 18926726BACKGROUND
  • Rdesinski RE, Melnick AL, Creach ED, Cozzens J, Carney PA. The costs of recruitment and retention of women from community-based programs into a randomized controlled contraceptive study. J Health Care Poor Underserved. 2008 May;19(2):639-51. doi: 10.1353/hpu.0.0016.

    PMID: 18469433BACKGROUND

Study Officials

  • Alan L Melnick, MD, MPH

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Associate Professor

Study Record Dates

First Submitted

June 25, 2009

First Posted

June 26, 2009

Study Start

September 1, 2009

Primary Completion

May 1, 2013

Study Completion

May 1, 2015

Last Updated

March 30, 2016

Record last verified: 2016-03

Locations